Oxford, UK 12 July 2011 - PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by Avexa Limited to seek an out-licensing partner for apricitabine (ATC), a late-stage, novel treatment for HIV infection. The engagement will utilise PharmaVentures' global transactional expertise in the healthcare and investment business sectors.
Oxford UK, 28 June 2011: PharmaVentures, experts in deals and alliances, are pleased to announce that they have recently been engaged by two major pharmaceutical companies to divest three facilities in three continents.
Oxford, UK- June 27 2011 - PharmaDeals®, the publishing division of PharmaVentures, announced today the launch of PharmaDeals v4 Enterprise Edition, a new integrated resource with a comprehensive, searchable and interactive library of reports, articles, agreements, video, graphs and deal data. As well as access to new online content, the resource also provides users with a range of applications and tools for tracking, alerting and analysing information.
PharmaVentures today announced the appointment of Ping Shek as Senior Director in the Transactions division of Corporate Advisory working on a number of key M&A and divestment mandates in the healthcare business sector.
Oxford, UK, 22nd February 2011: PharmaDeals® research has revealed that the early stages of recovery are now evident within pharmaceutical deal making activity. The overall number of deals in 2010 grew relative to 2009, and whilst collaborative R&D deals continue to decline in numbers and value, licensing activity is on the increase.
Oxford, UK, August 19 2010: PharmaVentures, the company behind the PharmaDeals®; range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.
OXFORD, UK, June 7, 2010 /PRNewswire: PharmaTelevision® today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector.
Oxford, UK, May 11, 2010: PharmaTelevision® announced that as of today the groundbreaking online TV channel for the BioPharma industry, is teaming up with Reuters Insider, a new interactive on-demand video platform designed to change the way financial professionals consume and distribute news, research and information.
London and Oxford, United Kingdom – March 15, 2010: Matrix Corporate Capital ('Matrix') and PharmaVentures Limited ('PharmaVentures') today announced the signing of a Memorandum of Understanding ('MOU') covering strategic transactions in the biotech, pharmaceutical and med tech sectors. The companies will work together to identify licensing, buyout, investment, IPO and consolidation opportunities which bring together both strategic expertise and capital from Europe's dedicated healthcare investors.
PharmaTelevision Ltd announced today the launch of major new services to meet the growing demand for the production and dissemination of rich media content in the pharmaceutical and biotechnology sector. The company, a subsidiary of PharmaVentures, already provides the only online television channel dedicated to the bio-pharma industry, offering daily television news, analysis and feature interviews.